Showing results (41-50 of 87) with videos related to

Sort By:
Pageof 9
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|January 31, 2012
Doxycycline vs. macrolides in combination therapy for treatment of community-acquired pneumoniaB Teh, M L Grayson, P D R Johnson, et al.
Antimicrobial Agents and Chemotherapy|December 24, 2004
Comparison of three PCR primer sets for identification of vanB gene carriage in feces and correlation with carriage of vancomycin-resistant enterococci: interference by vanB-containing anaerobic bacilliS A Ballard, E A Grabsch, P D R Johnson, et al.
JAMA|March 1, 1995
Probing to bone in infected pedal ulcers. A clinical sign of underlying osteomyelitis in diabetic patientsM L Grayson, G W Gibbons, K Balogh, et al.
The Journal of Applied Bacteriology|October 1, 1995
In vitro inhibition of Helicobacter pylori NCTC 11637 by organic acids and lactic acid bacteriaP D Midolo, J R Lambert, R Hull, et al.
Epidemiology and Infection|June 17, 2016
A large outbreak of Campylobacter jejuni infection in a university college caused by chicken liver pâté, Australia, 2013C R M Moffatt, A Greig, M Valcanis, et al.
Bone Marrow Transplantation|October 2, 2003
Cytomegalovirus viral load monitoring after allogeneic bone marrow transplantation in patients receiving antiviral prophylaxisB P Howden, A Michaelides, D W Spelman, et al.
The Medical Journal of Australia|August 15, 1994
Cerebral sparganosis in an East Timorese refugeeW J Munckhof, M L Grayson, B J Susil, et al.
Journal of Clinical Microbiology|March 1, 1995
Random amplified polymorphic DNA and plasmid analyses used in investigation of an outbreak of multiresistant Klebsiella pneumoniaeD Eisen, E G Russell, M Tymms, et al.
Pathology|January 10, 1998
Antimicrobial resistance testing of Helicobacter pylori: a comparison of Etest and disk diffusion methodsP D Midolo, J M Bell, J R Lambert, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 1, 1997
Cost-effectiveness of ampicillin/sulbactam versus imipenem/cilastatin in the treatment of limb-threatening foot infections in diabetic patientsP S McKinnon, J A Paladino, M L Grayson, et al.
Pageof 9